We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A blue beetle.

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

Protein structures.

Scientists Uncover the Cellular Functions of Proteins Integral to Inflammatory Diseases

Two hands holding up a nasal spray, a packet of white pills and a tissue.

Common Antibiotic Shows Promise in the Treatment of Respiratory Viral Infections

Rice Bran Nanoparticles Show Promise as Anti-Cancer Agent

Study Investigates How Aspirin Helps To Prevent Colorectal Cancer Development

Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injury

News

Medwell Capital and Spectral Diagnostics Announce Completion of Plan of Arrangement

Medwell acquires a further 33,333,333 Spectral common shares for $10 million.

NIH Study Finds Two Doses of HPV Vaccine may be as Protective as Full Course

The results of the study, based on data from a community-based clinical trial of Cervarix in Costa Rica.

Trophos Completes Patient Enrolment in Pivotal Efficacy Study of Olesoxime in SMA

Topline results expected in second half of 2013.

Critical Pharmaceuticals Announce Interim Results of CP024 Nasal hGH Phase 1 Program

Clinical data show that CP024 is able to induce IGF-1 to the same levels as a subcutaneous injection of the marketed product.

4SC’s Resminostat Meets Primary Efficacy Endpoint in Phase II Trial in Hodgkin’s Lymphoma

Resminostat shows substantial clinical benefit in heavily pre-treated relapsed/refractory HL patients.

Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or ‘Off-The-Shelf’ Stem Cell Treatment for Heart Attacks

Company receives clearance to begin Phase 2 clinical trial for Revascor™ in conjunction with angioplasty and stent procedures.

New Drugs Hope for Dangerous Yeast Infections

Researchers from ICL have now found out yeast cells identify and attach to human tissue in order to colonize it and cause an infection.

uOttawa and OHRI Scientists Make Historic Breakthrough in Cancer Therapy Trial

The study shows that an intravenously-delivered viral therapy can consistently infect and spread within tumours without harming normal tissues in humans.

Australian Anti-Cancer Drug Company Granted Important New Patent

The patent provides protection for the company’s platform technology until the year 2025.

NiKem Research and Chiesi Farmaceutici Extend Research Collaboration

Chiesi Farmaceutici and NiKem Research announce details of their extended research collaboration within the respiratory therapeutic area.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter